| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/21/2013 | WO2013038195A2 Pharmaceutical nanoparticle compositions |
| 03/21/2013 | WO2013037883A1 New use of melatonine |
| 03/21/2013 | WO2013037736A1 Indanyl-substituted 4,5,6,7-tetrahydro-1h-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them |
| 03/21/2013 | WO2013037713A1 Combinations comprising a s1p receptor modulator |
| 03/21/2013 | WO2013037499A1 Inhibitors of nox4 expression and/or nox4 function and their use in the prevention and treatment of nerve injury and/or neuropathic pain |
| 03/21/2013 | WO2013037390A1 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| 03/21/2013 | WO2013037389A1 Indanyl-substituted 4,5,6,7-tetrahydro-1h-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them |
| 03/21/2013 | WO2013037207A1 N-(3-pyridine formoxyl)- 3,5-dimethyl-1- amantadine or its pharmaceutical salt for treating vascular dementia |
| 03/21/2013 | WO2012164055A3 New compounds, synthesis and use thereof in the treatment of pain |
| 03/21/2013 | WO2012161527A3 Composition for preventing or treating neurodegenerative diseases, containing sandal tree extracts or fractions thereof as active ingredients |
| 03/21/2013 | WO2012134194A3 Herbal compositions for treating neurological diseases and improving memory impairment |
| 03/21/2013 | WO2012118409A3 Spirocyclic cyclopropanoic amino acids and drugs based thereon |
| 03/21/2013 | WO2012085648A9 Phosphorus-substituted quinoxaline-type piperidine compounds and uses thereof |
| 03/21/2013 | WO2011143872A9 Crystal form of (s)-4-hydroxy-2-oxo-1-pyrrolidine acetamide, preparation method and use thereof |
| 03/21/2013 | US20130072667 Use of rgm and its modulators |
| 03/21/2013 | US20130072550 PKC ACTIVATION AS A MEANS FOR ENHANCING sAPPalpha SECRETION AND IMROVING COGNITION USING BRYOSTATIN TYPE COMPOUNDS |
| 03/21/2013 | US20130072546 Treatment of methionine sulfoxide reductase a (msra) related diseases by inhibition of natural antisense transcript to msra |
| 03/21/2013 | US20130072527 Methods of using sustained release aminopyridine compositions |
| 03/21/2013 | US20130072522 Process for Making Modulators of Cystic Fibrosis Transmembrane Conductance Regulator |
| 03/21/2013 | US20130072517 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| 03/21/2013 | US20130072514 Sustained-Release Opioid Formulations and Methods of Use |
| 03/21/2013 | US20130072499 PIPERAZINE DERIVATIVES FOR BLOCKING Cav2.2 CALCIUM CHANNELS |
| 03/21/2013 | US20130072481 mTOR SELECTIVE KINASE INHIBITORS |
| 03/21/2013 | US20130072478 N-(3-(2-amino-6,6-difluoro-4,4a,5,6,7,7a-hexahydro-cyclopenta[e][1,3]oxazin-4-yl)-phenyl-amides as bace1 inhibitors |
| 03/21/2013 | US20130072472 Noribogaine salt ansolvates |
| 03/21/2013 | US20130072468 Substituted piperazines as cb1 antagonists |
| 03/21/2013 | US20130072438 Opioid peptide esters and methods of use |
| 03/21/2013 | US20130072425 Saposin-a derived peptides and uses thereof |
| 03/21/2013 | US20130072421 Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt) |
| 03/21/2013 | US20130071490 X-ray contrast media compositions and methods of using the same to treat, reduce or delay the onset of cns inflammation and inflammation associated conditions |
| 03/21/2013 | US20130071487 Xenon-based inhalable drug for preventing addiction relapses in humans |
| 03/21/2013 | US20130071435 Novel herbal formulation for the modulation of immune system of hiv infected patients and a process of preparation thereof |
| 03/21/2013 | US20130071410 Human CGRP Receptor Binding Proteins |
| 03/21/2013 | US20130071337 Interomone Compositions and Their Use to Modify Behavior in Different Vertebrate Species |
| 03/21/2013 | US20130071320 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 03/21/2013 | CA2848540A1 Therapeutic compounds |
| 03/21/2013 | CA2848231A1 New use of melatonine |
| 03/21/2013 | CA2847698A1 Nanoconjugates able to cross the blood-brain barrier |
| 03/21/2013 | CA2846768A1 Combinations comprising a s1p receptor modulator |
| 03/21/2013 | CA2845673A1 Pharmaceutical nanoparticle compositions |
| 03/21/2013 | CA2845473A1 Indanyl-substituted 4,5,6,7-tetrahydro-1h-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them |
| 03/21/2013 | CA2845007A1 Noribogaine salt ansolvates |
| 03/20/2013 | EP2570411A1 Nitrogen-containing heterocyclic compound having kynurenine production inhibitory activity |
| 03/20/2013 | EP2570410A1 1-[(4-hydroxypridin-4-yl) methyl]pyridine-2(1h)-one derivatives, preparation methods and uses thereof |
| 03/20/2013 | EP2570409A1 Aralkyl diamine derivatives and uses thereof as antidepressant |
| 03/20/2013 | EP2570408A1 Hexaketide compound and medicinal use thereof |
| 03/20/2013 | EP2570155A2 Treatment of depressive disorders |
| 03/20/2013 | EP2570136A2 Protein A compositions and methods of use |
| 03/20/2013 | EP2570132A2 Method for preparing novel processed ginseng or an extract thereof, the usually minute ginsenoside content of which is increased |
| 03/20/2013 | EP2570126A1 Use of melatonine for treating acute alcohol intoxication |
| 03/20/2013 | EP2569420A2 Method and composition for inducing human pluripotent stem cells |
| 03/20/2013 | EP2569327A1 Eif4e binding peptides |
| 03/20/2013 | EP2569320A2 (+)-3-hydroxymorphinan-based polycycle derivatives as neuroprotectants |
| 03/20/2013 | EP2569319A1 Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes |
| 03/20/2013 | EP2569306A1 Heteroaryloxycarbocyclyl compounds as pde10 inhibitors |
| 03/20/2013 | EP2569305A1 Substituted n-heteroaryl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof |
| 03/20/2013 | EP2569304A1 Substituted n-heteroaryl spirolactam bipyrrolidines, preparation and therapeutic use thereof |
| 03/20/2013 | EP2569303A1 Substituted n-alkyl and n-acyl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof |
| 03/20/2013 | EP2569302A1 Heteroaryloxyheterocyclyl compounds as pde10 inhibitors |
| 03/20/2013 | EP2569300A1 Nitrogen heterocyclic compounds useful as pde10 inhibitors |
| 03/20/2013 | EP2569299A1 Nitrogen- heterocyclic compounds as phosphodiesterase 10 inhibitors |
| 03/20/2013 | EP2569298A1 Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments |
| 03/20/2013 | EP2569297A1 Substituted n-heterocycloalkyl bipyrrolidinylphenyl amide derivatives, preparation and therapeutic use thereof |
| 03/20/2013 | EP2569296A1 Substituted n-phenyl spirolactam bipyrrolidines, preparation and therapeutic use thereof |
| 03/20/2013 | EP2569293A1 Pyrazolopyridines as inhibitors of the kinase lrrk2 |
| 03/20/2013 | EP2569291A1 Selective glycosidase inhibitors and uses thereof |
| 03/20/2013 | EP2569019A2 Compositions, methods and systems for the synthesis and use of imaging agents |
| 03/20/2013 | EP2568811A1 Treatment of mci and alzheimer's disease |
| 03/20/2013 | EP2568809A1 Heterocyclic sulfone mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| 03/20/2013 | CN1606554B Beta-lactamyl vasopressin v1a antagonists |
| 03/20/2013 | CN1541107B Growth factor complex |
| 03/20/2013 | CN102985412A 3-amino-5,6-dihydro-1h-pyrazin-2-one derivatives useful for the treatement of alzheimer's disease and other forms of dementia |
| 03/20/2013 | CN102985411A Imaging agents for detecting neurological disorders |
| 03/20/2013 | CN102985407A 8-hydroxy-quinoline derivatives |
| 03/20/2013 | CN102985085A Methods for treating bipolar disorder |
| 03/20/2013 | CN102977212A Compositions comprising anti-IGF-1r antibodies and methods for their production |
| 03/20/2013 | CN102977201A Scoropendra subspinipes mutilans polypeptide toxin mu-SLPTX-Ssm6a and gene and application thereof |
| 03/20/2013 | CN102977111A Beta1-epinephrine receptor analgesia with effect of improving Alzheimer disease |
| 03/20/2013 | CN102977106A Kappa opioid agonist with peripheral analgesia effect |
| 03/20/2013 | CN102977087A Application of selective alpha2A receptor stimulant in treating alzheimer disease |
| 03/20/2013 | CN102977086A Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators - 842 |
| 03/20/2013 | CN102977054A Application of selective alpha2A receptor stimulant in treating alzheimer disease |
| 03/20/2013 | CN102977025A (-)-meptazinol phenylamino carbamate-L-(+)-tartrate type-III crystal |
| 03/20/2013 | CN102977024A (-)-meptazinol phenylamino carbamate-L-(+)-tartrate type-I crystal |
| 03/20/2013 | CN102977023A (-)-meptazinol phenylamino carbamate-L-(+)-tartrate type-III crystal |
| 03/20/2013 | CN102977015A Nitrogen-containing heteroaryl compounds and their use in increasing endogeneous erythropoietin |
| 03/20/2013 | CN102976928A Compounds for reducing uric acid |
| 03/20/2013 | CN102973924A Brain-tonic anti-aging Chinese patent medicine and preparation method thereof |
| 03/20/2013 | CN102973903A Chinese patent medicine capsule for curing migraine |
| 03/20/2013 | CN102973900A Traditional Chinese medicine composition for treating anxiety neurosis |
| 03/20/2013 | CN102973880A Bath powder for treating neurasthenia |
| 03/20/2013 | CN102973877A Pharmaceutical composition for treating depression |
| 03/20/2013 | CN102973870A Decanting chewable tablet and preparation method thereof |
| 03/20/2013 | CN102973868A Traditional Chinese medicine combination for treating ischialgia |
| 03/20/2013 | CN102973867A Drug for overcoming fear and calming nerves |
| 03/20/2013 | CN102973853A Traditional Chinese medicine composition for treating intractable headache |
| 03/20/2013 | CN102973814A Formula of traditional Chinese medicine capable of purifying blood, protecting heart and brain, and enhancing immunity, and preparation method thereof |
| 03/20/2013 | CN102973813A Capsules used for treating migraine |
| 03/20/2013 | CN102973799A Pill used for post-anesthesia nerve injury |
| 03/20/2013 | CN102973798A Liver-calming and pressure-reducing medicament |